Safety and Dose-Finding Study of DTX301 (scAAV8OTC) in Adults With Late-Onset Ornithine Transcarbamylase (OTC) Deficiency
Clinical trial NCT02991144 · COMPLETED
Trial details
- NCT number
- NCT02991144
- Sponsor
- Ultragenyx Pharmaceutical Inc
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-31
- Primary completion
- 2021-12-16
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.